Cargando…

Assessment of COVID-19 RT-PCR Positive Symptomatic Patients With Clinical, Hematological, and Radiological Parameters Among Three Groups: A Comparative Study

Background: Nearly 70.1 million individuals have been infected by the pandemic viral disease known as coronavirus disease 2019 (COVID-19), which was first discovered in China and is caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). This disease is r...

Descripción completa

Detalles Bibliográficos
Autores principales: G, Natesh, Parivakkam Mani, Anbumaran, Vadivelu, Gangadharan, Selvaraj, Preethi, Yadav, Sankalp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308249/
https://www.ncbi.nlm.nih.gov/pubmed/37398817
http://dx.doi.org/10.7759/cureus.39681
_version_ 1785066207643172864
author G, Natesh
Parivakkam Mani, Anbumaran
Vadivelu, Gangadharan
Selvaraj, Preethi
Yadav, Sankalp
author_facet G, Natesh
Parivakkam Mani, Anbumaran
Vadivelu, Gangadharan
Selvaraj, Preethi
Yadav, Sankalp
author_sort G, Natesh
collection PubMed
description Background: Nearly 70.1 million individuals have been infected by the pandemic viral disease known as coronavirus disease 2019 (COVID-19), which was first discovered in China and is caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). This disease is responsible for the deaths of 6 million people. India ranks third in the total number of cases. The purpose of this study was to classify COVID-19 patients according to several criteria and to determine which clinical, hematological, and radiological indicators were most important in their care. Materials and methods: An analytical cross-sectional study was conducted on a total of 70 symptomatic patients who tested positive for COVID-19 reverse transcription polymerase chain reaction (RT-PCR) and were hospitalized at the Saveetha Medical College and Hospital in Chennai, Tamil Nadu, India, for the duration of the study. Comorbidities and oxygen reliance were taken into consideration while classifying patients into one of three categories. Initial symptoms, as well as hematological (interleukin-6 (IL-6), erythrocyte sedimentation rate (ESR), c-reactive protein (CRP), D-dimer, serum ferritin, and total cell counts) and radiographic (X-ray and computed tomography (CT) of the thorax) characteristics, were taken and analyzed among the different groups. Results: According to our research, the symptom of fever was the most common, accounting for 84.3% of all cases. This was followed by breathlessness (55.7%), myalgia (31.4%), dry cough (27.1%), sore throat (24.3%), cough with expectoration (20%), loose stools (12.9%), loss of taste (12.9%), and smell (11.4%). Although there was a large amount of variation in D-dimer, with Category C having the highest values, there was only a minor amount of variation in ESR and CRP. The X-ray and CT scans of the chest showed substantial differences between the groups, with CT findings such as COVID-19 Reporting and Data System (CO-RADS) and CT severity score, consolidation, crazy paving pattern, and vascular dilatation showing a wide range of differences between the groups. Conclusions: To facilitate easier treatment and place more attention on radiological characteristics using D-dimer, treating physicians are required to categorize COVID-19 patients into several groups. Patients who need oxygen support were included in this category.
format Online
Article
Text
id pubmed-10308249
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-103082492023-06-30 Assessment of COVID-19 RT-PCR Positive Symptomatic Patients With Clinical, Hematological, and Radiological Parameters Among Three Groups: A Comparative Study G, Natesh Parivakkam Mani, Anbumaran Vadivelu, Gangadharan Selvaraj, Preethi Yadav, Sankalp Cureus Infectious Disease Background: Nearly 70.1 million individuals have been infected by the pandemic viral disease known as coronavirus disease 2019 (COVID-19), which was first discovered in China and is caused by a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). This disease is responsible for the deaths of 6 million people. India ranks third in the total number of cases. The purpose of this study was to classify COVID-19 patients according to several criteria and to determine which clinical, hematological, and radiological indicators were most important in their care. Materials and methods: An analytical cross-sectional study was conducted on a total of 70 symptomatic patients who tested positive for COVID-19 reverse transcription polymerase chain reaction (RT-PCR) and were hospitalized at the Saveetha Medical College and Hospital in Chennai, Tamil Nadu, India, for the duration of the study. Comorbidities and oxygen reliance were taken into consideration while classifying patients into one of three categories. Initial symptoms, as well as hematological (interleukin-6 (IL-6), erythrocyte sedimentation rate (ESR), c-reactive protein (CRP), D-dimer, serum ferritin, and total cell counts) and radiographic (X-ray and computed tomography (CT) of the thorax) characteristics, were taken and analyzed among the different groups. Results: According to our research, the symptom of fever was the most common, accounting for 84.3% of all cases. This was followed by breathlessness (55.7%), myalgia (31.4%), dry cough (27.1%), sore throat (24.3%), cough with expectoration (20%), loose stools (12.9%), loss of taste (12.9%), and smell (11.4%). Although there was a large amount of variation in D-dimer, with Category C having the highest values, there was only a minor amount of variation in ESR and CRP. The X-ray and CT scans of the chest showed substantial differences between the groups, with CT findings such as COVID-19 Reporting and Data System (CO-RADS) and CT severity score, consolidation, crazy paving pattern, and vascular dilatation showing a wide range of differences between the groups. Conclusions: To facilitate easier treatment and place more attention on radiological characteristics using D-dimer, treating physicians are required to categorize COVID-19 patients into several groups. Patients who need oxygen support were included in this category. Cureus 2023-05-30 /pmc/articles/PMC10308249/ /pubmed/37398817 http://dx.doi.org/10.7759/cureus.39681 Text en Copyright © 2023, G et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Infectious Disease
G, Natesh
Parivakkam Mani, Anbumaran
Vadivelu, Gangadharan
Selvaraj, Preethi
Yadav, Sankalp
Assessment of COVID-19 RT-PCR Positive Symptomatic Patients With Clinical, Hematological, and Radiological Parameters Among Three Groups: A Comparative Study
title Assessment of COVID-19 RT-PCR Positive Symptomatic Patients With Clinical, Hematological, and Radiological Parameters Among Three Groups: A Comparative Study
title_full Assessment of COVID-19 RT-PCR Positive Symptomatic Patients With Clinical, Hematological, and Radiological Parameters Among Three Groups: A Comparative Study
title_fullStr Assessment of COVID-19 RT-PCR Positive Symptomatic Patients With Clinical, Hematological, and Radiological Parameters Among Three Groups: A Comparative Study
title_full_unstemmed Assessment of COVID-19 RT-PCR Positive Symptomatic Patients With Clinical, Hematological, and Radiological Parameters Among Three Groups: A Comparative Study
title_short Assessment of COVID-19 RT-PCR Positive Symptomatic Patients With Clinical, Hematological, and Radiological Parameters Among Three Groups: A Comparative Study
title_sort assessment of covid-19 rt-pcr positive symptomatic patients with clinical, hematological, and radiological parameters among three groups: a comparative study
topic Infectious Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308249/
https://www.ncbi.nlm.nih.gov/pubmed/37398817
http://dx.doi.org/10.7759/cureus.39681
work_keys_str_mv AT gnatesh assessmentofcovid19rtpcrpositivesymptomaticpatientswithclinicalhematologicalandradiologicalparametersamongthreegroupsacomparativestudy
AT parivakkammanianbumaran assessmentofcovid19rtpcrpositivesymptomaticpatientswithclinicalhematologicalandradiologicalparametersamongthreegroupsacomparativestudy
AT vadivelugangadharan assessmentofcovid19rtpcrpositivesymptomaticpatientswithclinicalhematologicalandradiologicalparametersamongthreegroupsacomparativestudy
AT selvarajpreethi assessmentofcovid19rtpcrpositivesymptomaticpatientswithclinicalhematologicalandradiologicalparametersamongthreegroupsacomparativestudy
AT yadavsankalp assessmentofcovid19rtpcrpositivesymptomaticpatientswithclinicalhematologicalandradiologicalparametersamongthreegroupsacomparativestudy